aspirin and apixaban

aspirin has been researched along with apixaban in 123 studies

Research

Studies (123)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	2 (1.63)	29.6817
2010's	89 (72.36)	24.3611
2020's	32 (26.02)	2.80

Authors

Authors	Studies
Bai, T; Feng, Q; Guo, T; Jia, J; Li, X; Liu, Y; Pei, J; Song, Y; Wu, L; Wu, S; Zhang, Y; Zheng, X	1
Dranchak, PK; Huang, R; Inglese, J; Lamy, L; Oliphant, E; Queme, B; Tao, D; Wang, Y; Xia, M	1
Crain, EJ; Watson, CA; Wong, PC	1
Alexander, JH; Becker, RC; Bhatt, DL; Cools, F; Crea, F; Dellborg, M; Fox, KA; Goodman, SG; Harrington, RA; Huber, K; Husted, S; Lewis, BS; Lopez-Sendon, J; Mohan, P; Montalescot, G; Ruda, M; Ruzyllo, W; Verheugt, F; Wallentin, L	1
Connolly, SJ; Diaz, R; Eikelboom, JW; Flaker, G; Hart, R; Hohnloser, S; Joyner, C; Lawrence, J; O'Donnell, M; Pais, P; Pogue, J; Synhorst, D; Yusuf, S	1
Cohen, AT; Nandini, B; Ota, S; Wills, JO	1
Afzal, R; Avezum, A; Budaj, A; Commerford, P; Connolly, SJ; Dans, AL; Diaz, R; Diener, HC; Eikelboom, J; Flaker, G; Golitsyn, S; Gonzalez-Hermosillo, A; Hart, R; Hohnloser, SH; Jansky, P; Joyner, C; Kim, JH; Lanas-Zanetti, F; Lawrence, J; Lewis, BS; Lewis, G; Lip, GY; Munawar, M; O'Donnell, M; Pais, P; Parkhomenko, A; Sim, KH; Talajic, M; Tan, RS; Van Mieghem, W; Yusuf, S; Zhu, J	1
Hart, RG	1
Owen, A	1
Lynch, DR	1
Alexander, JH; Atar, D; Bhatt, DL; Cools, F; Cornel, JH; Darius, H; De Caterina, R; Diaz, R; Flather, M; Geraldes, M; Goodman, S; Harrington, RA; He, Y; Huber, K; Husted, SE; James, S; Jansky, P; Keltai, M; Kilaru, R; Lawrence, J; Leiva-Pons, JL; Liaw, D; Lopes, RD; Lopez-Sendon, J; Mohan, P; Ogawa, H; Pais, P; Parkhomenko, A; Ruda, M; Ruzyllo, W; Verheugt, FW; Vinereanu, D; Wallentin, L; White, H	1
Abbate, R; De Caterina, R	1
Flaker, G; Littrell, R	1
Connolly, SJ; Diener, HC; Eikelboom, J; Hankey, GJ; Hart, RG; Hohnloser, SH; Joyner, CD; Lip, GY; O'Donnell, M; Shestakovska, O; Yusuf, S	1
Kate, MP; Shuaib, A	1
Agarwal, S; Hachamovitch, R; Menon, V	1
Halperin, JL; Varughese, CJ	1
Bhatt, DL; Kar, S	1
Anglade, MW; Coleman, CI; Hagstrom, K; Kluger, J; Lee, S; Meng, J	1
Connolly, SJ; De Caterina, R; Eikelboom, JW; Gao, P; Hart, RG; Husted, S; O'Donnell, M; Paolasso, E; Yusuf, S	1
Budaj, A; Connolly, SJ; Eikelboom, JW; Flaker, GC; Hart, RG; Husted, S; Kaatz, S; Lip, GY; Shestakovska, O; Yusuf, S	1
Connolly, S; Eikelboom, J; Flaker, G; Hart, R; Lanas, F; Lip, GY; Shestakovska, O; Xavier, D; Yusuf, S	1
Keating, GM	1
Finsterer, J; Stöllberger, C	1
Diener, HC	1
Bates, P; Culpan, P; El-Daly, I; Reidy, J	1
Al-Majzoub, O; Assiri, A; Donovan, JL; Kanaan, AO; Silva, M	1
Kansal, AR; Pokora, T; Sorensen, SV; Zheng, Y	1
Cameron, C; Carrier, M; Castellucci, LA; Clifford, T; Coyle, D; Gandara, E; Le Gal, G; Rodger, MA; Wells, G; Wells, PS	1
Dugdale, M; Fabian, TC; Gordon, JL; Lee, MD	1
Amin, A; Deitelzweig, S; Graham, J; Jing, Y; Lin, J; Makenbaeva, D; Wiederkehr, D	1
Alexander, JH; Alings, M; Atar, D; Aylward, P; Goto, S; Granger, CB; Hanna, M; Huber, K; Husted, S; Lewis, BS; Lopes, RD; McMurray, JJ; Pais, P; Pouleur, H; Steg, PG; Thomas, L; Verheugt, FW; Wallentin, L; Wojdyla, DM	1
Diez-Ewald, M	1
Gupta, K; Singh, D; Vacek, JL	1
Dorian, P; Hernandez, L; Iloeje, U; Kongnakorn, T; Kuznik, A; Lanitis, T; Lip, GY; Liu, LZ; Phatak, H; Rublee, DA	1
Gnall, EM; Ice, DS; Kowey, PR; Shapiro, TA	1
Connolly, SJ; Coppens, M; Eikelboom, JW; Shestakovska, O; Synhorst, D; Yusuf, S	1
Gislason, G; Sørensen, R	1
Cotté, FE; Durand-Zaleski, I; Gaudin, AF; Kachaner, I; Kongnakorn, T; Lanitis, T	1
Connolly, S; Eikelboom, J; Hart, RG; Lip, GY; Shestakovska, O; Yusuf, S	1
De Geer, A; Jacobson, L; Kongnakorn, T; Lanitis, T	1
Annemans, L; Kongnakorn, T; Lanitis, T; Lieven, A; Marbaix, S; Thijs, V	1
Buxton, DE; Gabrilovich, MI; Lykins, DM; McMillen, SM; Onadeko, OOA	1
Han, J; Jiang, W; Lei, H; Yang, F; Zhao, G	1
Deitelzweig, SB; Jing, Y; Makenbaeva, D; Swindle, JP	1
Forslund, T; Hjemdahl, P; Holmström, M; Johnsson, H; von Euler, M; Wettermark, B	1
Bultas, J	1
Agewall, S; Huber, K; Lip, GY; Rubboli, A	1
Dorian, P; Kongnakorn, T; Lanitis, T; Lip, GY; Mardekian, J; Phatak, H	1
Ang, ES; De Silva, DA; Fabiaña, N; Ramaswami, AP	1
Avezum, A; Connolly, SJ; Diaz, R; Eikelboom, JW; Hart, RG; Lanas, F; Ng, KH; Shestakovska, O; Yusuf, S	1
Forslund, T; Hjemdahl, P; Wettermark, B	1
Hussein, A; Saliba, W; Wazni, OM	1
Akehurst, RL; Amorosi, SL; Armstrong, SO; Brereton, N; Hertz, DS; Holmes, DR; Reddy, VY	1
Baker, D; Narasimhan, S; Wilsmore, B	1
Bhatt, DL; Qamar, A	1
Barra, ME; Connors, JM; Fanikos, J; Goldhaber, SZ; Piazza, G; Sylvester, KW	1
Aonuma, K; Gosho, M; Hoshi, T; Nogami, A; Sato, A	1
Correa Ballester, M; Hernández Martín, J; Vial Escolano, R	1
Avezum, A; Connolly, S; Dias, R; Diener, HC; Eikelboom, JW; Flaker, G; Gladstone, DJ; Hart, RG; Lewis, G; O'Donnell, MJ; Sharma, M; Smith, EE; Yusuf, S; Zhu, J	1
Benedetti, R; Fenoglio, L; Imberti, D; Pomero, F	1
Musgrave, KM; Powell, J	1
Ademi, Z; Liew, D; Pasupathi, K	1
Bäezner, H; Brachmann, J; Gahn, G; Gawaz, M; Geisler, T; Jander, S; Jung, W; Keller, T; Kimmig, H; Liman, J; Lindner, A; Ludolph, AC; Meisner, C; Nägele, T; Petzold, GC; Poli, S; Schabet, M; Schlegel, U; Schmid, E; Schön, F; Schreieck, J; Schrickel, JW; Wachter, R; Ziemann, U; Zuern, CS	1
Athanasakis, K; Bilitou, A; Boubouchairopoulou, N; Karampli, E; Kyriopoulos, J; Savvari, P; Tarantilis, F	1
Al-Khatib, SM; Alexander, JH; Bushnell, CD; Diener, HC; Easton, JD; Gabriel Melo de Barros E Silva, P; Granger, CB; Guimarães, PO; Hanna, M; Held, C; Kolls, BJ; Lopes, RD; Thomas, L; Wallentin, L; Wojdyla, DM	1
Barmparas, G; Bosarge, P; Brown, CV; Bukur, M; Carrick, MM; Catalano, RD; Coimbra, R; Holly-Nicolas, J; Inaba, K; Kaminski, S; Klein, AL; Kobayashi, L; Kopelman, T; Ley, EJ; Martinez, EM; Moore, FO; Murry, J; Nirula, R; Paul, D; Quick, J; Rivera, O; Schreiber, M	1
Abdul-Rahim, AH; Alexander, JH; Connolly, SJ; Flaker, GC; Granger, CB; Guimarães, PO; Hanna, M; Lees, KR; Lopes, RD; McMurray, JJV; Wallentin, L; Wang, J; Wojdyla, DM	1
Churilov, L; Hardidge, AJ; Suen, K; Westh, RN	1
Chang, S; Chang, Y; Lu, S; Sun, Q; Zhang, Y	1
Jolobe, OMP	1
Chen, X; Jin, Y; Wang, Z; Xiang, Y; Zhao, Y; Zheng, J	1
Brodie, MM; Newman, JC; Rockey, DC; Smith, T	1
Chan, PH; Kwok, OH; Lam, CC; Lam, YY; Siu, CW; Wong, CK	1
Alexander, JH; Bahit, MC; Granger, CB; Halvorsen, S; Huber, K; Jones, WS; Kopin, D; Lewis, BS; Lopes, RD; Parkhomenko, A; Sherwood, MW; Verheugt, FWA; Vinereanu, D; Wallentin, L; Wojdyla, DM	1
Battistella, M; Cameron, K; Farrell, A; Feldberg, J; Ma, J; Patel, P; Sivarajahkumar, S	1
Alexander, JH; Darius, H; Goodman, SG; Granger, CB; Liaw, D; Lopes, RD; Mehran, R; Vora, AN; Windecker, S	1
Azboy, I; Groff, H; Parvizi, J	1
Krug, K; Laux, G; Peters-Klimm, F; Schwill, S; Szecsenyi, J; van Lieshout, J; Wensing, M	1
Chiang, CE; Huang, WY; Lee, M; Ovbiagele, B; Singer, DE; Weng, HH; Wu, YL	1
Ahmad, A; Al-Khatib, SM; Blank, M; Coylewright, M; DiBattiste, P; Gersh, BJ; Granger, CB; Healey, JS; Hedrich, O; Hylek, EM; Kline-Rogers, E; Mendys, P; Mirro, MJ; Naccarelli, G; Patel, P; Peterson, ED; Pokorney, SD; Ruff, CT; Rutman, H; Stockbridge, N; Temple, R	1
Alexander, JH; Aronson, R; Averkov, O; Bahit, MC; Berwanger, O; Budaj, A; Darius, H; Goodman, SG; Granger, CB; Heizer, G; Hijazi, Z; Li, J; Lopes, RD; Massaro, T; Mehran, R; Parkhomenko, A; Sinnaeve, P; Storey, RF; Thiele, H; Vinereanu, D; Vora, AN; Windecker, S	1
Arya, R; Benjamin, R; Cornelius, V; Czuprynska, J; Patel, JP; Patel, RK; Roberts, LN; Sayar, Z	1
Imberti, D; Mastroiacovo, D; Pomero, F	1
Gremmel, T; Niessner, A; Sulzgruber, P	1
Mukherjee, D	1
Alexander, JH; Goodman, SG; Hagström, E; Harrington, RA; Lopes, RD; Neely, ML; Sharma, A; Wallentin, L; Wojdyla, DM	1
Albendín Iglesias, H; Arregui Montoya, F; Bailén Lorenzo, JL; Caro Martínez, C; Cerezo Manchado, JJ; Elvira Ruiz, G; Flores Blanco, PJ; García Alberola, A; Lova Navarro, A; Manzano-Fernández, S; Pascual Figal, DA	1
Abbate, O; Black, CK; Camden, RC; Evans, KK; Fan, KL; Lu, K	1
Arachchillage, DRJ; Farag, M; Gorog, DA; Gue, Y; Lip, GYH; Spinthakis, N; Srinivasan, M; Wellsted, D	1
Alexander, JH; Aronson, R; Averkov, O; Budaj, A; Darius, H; Goodman, SG; Granger, CB; Guimaraes, PO; Kobalava, Z; Kong, DF; Lopes, RD; Mehran, R; Mehta, RH; Mirza, Z; Parkhomenko, A; Quadros, A; Thiele, H; Vora, AN; Windecker, S; Wojdyla, DM	1
Alexander, JH; Aronson, R; Aschermann, M; Brieger, D; Cura, F; Darius, H; de Waha-Thiele, S; Engstrøm, T; Fridrich, V; Goodman, SG; Granger, CB; Halvorsen, S; Heizer, G; Huber, K; Jones, WS; Jones-Burton, C; Kang, HJ; Leiva-Pons, JL; Lewis, BS; Lopes, RD; Malaga, G; Massaro, T; Mehran, R; Meneveau, N; Merkely, B; Milicic, D; Morais, J; Potpara, TS; Raev, D; Sabaté, M; Welsh, RC; Windecker, S; Xavier, D	1
Barrientos, M; Fang, MC; Ramaprasad, A; Schwartz, JB; Tarn, DM; Wang, AY	1
Bhandari, M; Chernov, D; Hassan, F; Karavassilis, ME	1
Alexander, JH; Aronson, R; Goodman, SG; Granger, CB; Leonardi, S; Lopes, RD; Mehran, R; Storey, RF; Thiele, H; Thomas, L; Valgimigli, M; Vinereanu, D; Vora, AN; Windecker, S; Wojdyla, DM	1
Liao, YWB; Wang, TKM	1
Finniss, M; Helton, T; Khalid, M; Khan, AA; Murtaza, G	1
Dickson, SD; Govea, A; Penny, W; Taleb, A; Wiernek, S	1
Alexander, JH; Aronson, R; Goodman, SG; Granger, CB; Lopes, RD; Mehran, R; Thomas, L; Vora, AN; Windecker, S; Wojdyla, D	1
Agudelo, V; Arzamendi, D; Camara, O; Freixa, X; Mill, J; Olivares, AL; Regueiro, A	1
Edward, JA; Gopal, RK	1
Darius, H	1
Agati, LB; Bernardi, WH; Biagioni, RB; Caffaro, RA; Casella, IB; Comerota, AJ; de Freitas Soares, BL; Fidelis, RJR; Fioranelli, A; Flumignan, RLG; Joviliano, EE; Junior, VC; Lopes, RD; Ramacciotti, E; Sacilotto, R; Sobreira, ML; Van Bellen, B; Wolosker, N	1
Fernandez, S; Lenoir, C; Rollason, V; Samer, C	1
Hoffer, EP	1
Alexander, JH; Alings, M; De Caterina, R; Eikelboom, JW; Ezekowitz, MD; Granger, CB; Held, C; Hijazi, Z; Huber, K; Hylek, EM; Lindbäck, J; Lopes, RD; Oldgren, J; Siegbahn, A; Vinereanu, D; Wallentin, L	1
Kwon, O; Masic, D; Rech, MA	1
Burton, BJL; Canepa, C; Qidwai, U; Yang, Y	1
Cho, HJ; Choi, HY; Choi, S; Jang, HJ; Jang, SS; Jeon, S; Kim, DE; Kim, H; Kim, J; Kim, K; Kim, YD; Kwon, IC; Lee, KY; Lee, SK; Nahrendorf, M; Ryu, WS; Schellingerhout, D	1
Birlea, M; Hassell, KL; Hughes, HN; Schofield, JR	1
Alexander, JH; Aronson, R; Bahit, MC; Berwanger, O; Darius, H; de Waha-Thiele, S; Granger, CB; Halvorsen, S; Hijazi, Z; Li, Z; Lopes, RD; Mehran, R; Parkhomenko, A; Sinnaeve, P; Storey, RF; Windecker, S; Wojdyla, DM	1
Matoba, S; Ookura, T; Shoji, K; Yanishi, K; Zen, K	1
Chen, L; Devi Shamloll, Y; Jiang, Z; Jin, J; Xiao, M; Zhuo, X	1
Alexandris-Souphis, T; Ali, MA; Barnes, GD; Decamillo, D; Errickson, J; Froehlich, JB; Haymart, B; Kaatz, S; Kline-Rogers, E; Kong, X; Kozlowski, JH; Krol, GD; Li, Y; Schaefer, JK; Shankar, SR; Sood, SL	1
Baucom, AL; Beach, S; Bledsoe, JR; Brooks, MM; Castro, L; Connors, JM; Eng, H; Everett, B; Fu, Z; Haight, DO; Handberg, E; Hou, PC; Kindzelski, A; Kirwan, BA; Krishnan, JA; Lin, JY; Majercik, S; Martin, D; Pepine, CJ; Ridker, PM; Sciurba, FC; Shapiro, NL; Venugopal, V; Wilson, JW; Wisniewski, S; Zaharris, E; Zhong, Y	1
Dhanda, D; Di Fusco, M; Kang, A; Kongnakorn, T; Polanco, C; Rivolo, S; Savone, M; Skandamis, A; Soto, J	1
Alexander, JH; Aronson, R; Dehghani, P; Goodman, S; Granger, CB; Halvorsen, S; Lopes, R; Mehran, R; Parkhomenko, A; Vinereanu, D; Vora, AN; Welsh, RC; Windecker, S; Wojdyla, DM	1
Alexander, JH; Aronson, R; Bahit, MC; Berwanger, O; Dombrowski, KE; Goodman, SG; Granger, CB; Halvorsen, S; Jordan, JD; Kolls, BJ; Li, Z; Lopes, RD; Mehran, R; Thomas, L; Vinereanu, D; Vora, AN; Windecker, S; Wojdyla, DM	1
Ates, O; Dogan, M; Ersoz, E; Hacioglu Kasim, FB; Karaarslan, N; Ozbek, H; Yilmaz, I	1
Arghami, A; Crestanello, JA; Daly, RC; Dearani, JA; King, KS; Macielak, SA; Mazur, PK; Nei, SD; Schaff, HV; Viehman, JK	1
Blume, ED; Cetatoiu, MA; Daly, KP; Esteso, P; Fynn-Thompson, F; Hawkins, B; Kobayashi, RL; VanderPluym, C; Ventresco, C	1
Magee, M; McArthur, A; Schwartz, J; Tarn, D	1

Reviews

32 review(s) available for aspirin and apixaban

Article	Year
Progress of thrombus formation and research on the structure-activity relationship for antithrombotic drugs. European journal of medicinal chemistry, 2022, Jan-15, Volume: 228 Topics: Fibrinolytic Agents; Humans; Molecular Structure; Thrombosis	2022
VTE prophylaxis for the medical patient: where do we stand? - a focus on cancer patients. Thrombosis research, 2010, Volume: 125 Suppl 2 Topics: Anticoagulants; Aspirin; Fondaparinux; Heparin; Heparin, Low-Molecular-Weight; Humans; Morpholines; Neoplasms; Polysaccharides; Pyrazoles; Pyridones; Rivaroxaban; Thiophenes; Venous Thromboembolism; Warfarin	2010
Apixaban for the prevention of stroke in atrial fibrillation. Expert review of cardiovascular therapy, 2012, Volume: 10, Issue:2 Topics: Anticoagulants; Aspirin; Atrial Fibrillation; Clinical Trials, Phase II as Topic; Clinical Trials, Phase III as Topic; Factor Xa Inhibitors; Fibrinolytic Agents; Humans; Pyrazoles; Pyridones; Stroke; Warfarin	2012
Current trial-associated outcomes with warfarin in prevention of stroke in patients with nonvalvular atrial fibrillation: a meta-analysis. Archives of internal medicine, 2012, Apr-23, Volume: 172, Issue:8 Topics: Anticoagulants; Aspirin; Atrial Fibrillation; Azetidines; Benzylamines; Brain Ischemia; Clopidogrel; Female; Humans; Incidence; Male; Oligosaccharides; Primary Prevention; Pyrazoles; Pyridones; Randomized Controlled Trials as Topic; Stroke; Ticlopidine; Treatment Outcome; United States; Warfarin	2012
Prevention of stroke in patients with atrial fibrillation: anticoagulant and antiplatelet options. Journal of interventional cardiac electrophysiology : an international journal of arrhythmias and pacing, 2012, Volume: 35, Issue:1 Topics: Anticoagulants; Antithrombins; Aspirin; Atrial Fibrillation; Benzimidazoles; beta-Alanine; Clopidogrel; Dabigatran; Hemorrhage; Humans; Morpholines; Practice Guidelines as Topic; Pyrazoles; Pyridines; Pyridones; Risk Assessment; Rivaroxaban; Stroke; Thiazoles; Thiophenes; Thrombolytic Therapy; Ticlopidine; Warfarin	2012
Anticoagulants for the treatment of acute coronary syndrome in the era of new oral agents. Coronary artery disease, 2012, Volume: 23, Issue:6 Topics: Acute Coronary Syndrome; Administration, Oral; Anticoagulants; Antithrombins; Aspirin; Benzimidazoles; beta-Alanine; Clopidogrel; Dabigatran; Drug Therapy, Combination; Factor Xa Inhibitors; Hemorrhage; Heparin; Humans; Morpholines; Platelet Aggregation Inhibitors; Pyrazoles; Pyridones; Rivaroxaban; Thiophenes; Ticlopidine; Warfarin	2012
Apixaban: a review of its use for reducing the risk of stroke and systemic embolism in patients with nonvalvular atrial fibrillation. Drugs, 2013, Volume: 73, Issue:8 Topics: Aspirin; Atrial Fibrillation; Embolism; Fibrinolytic Agents; Humans; Pyrazoles; Pyridones; Stroke; Warfarin	2013
Thromboprophylaxis in patients with pelvic and acetabular fractures: A short review and recommendations. Injury, 2013, Volume: 44, Issue:12 Topics: Acetabulum; Anticoagulants; Aspirin; Benzimidazoles; beta-Alanine; Coumarins; Dabigatran; Fondaparinux; Fractures, Bone; Heparin; Humans; Mass Screening; Morpholines; Multiple Trauma; Pelvis; Polysaccharides; Pulmonary Embolism; Pyrazoles; Pyridones; Risk Assessment; Rivaroxaban; Thiophenes; Vena Cava Filters; Venous Thromboembolism	2013
Mixed treatment comparison meta-analysis of aspirin, warfarin, and new anticoagulants for stroke prevention in patients with nonvalvular atrial fibrillation. Clinical therapeutics, 2013, Volume: 35, Issue:7 Topics: Anticoagulants; Aspirin; Atrial Fibrillation; Benzimidazoles; beta-Alanine; Dabigatran; Data Interpretation, Statistical; Databases, Bibliographic; Double-Blind Method; Hemorrhage; Humans; Morpholines; Pyrazoles; Pyridones; Rivaroxaban; Stroke; Thiophenes; Warfarin	2013
Cost-effectiveness of new oral anticoagulants in the prevention of stroke in patients with atrial fibrillation. Best practice & research. Clinical haematology, 2013, Volume: 26, Issue:2 Topics: Administration, Oral; Aged; Anticoagulants; Aspirin; Atrial Fibrillation; Benzimidazoles; Cost-Benefit Analysis; Dabigatran; Drug Administration Schedule; Humans; Intracranial Hemorrhages; Morpholines; Pyrazoles; Pyridines; Pyridones; Randomized Controlled Trials as Topic; Rivaroxaban; Stroke; Thiophenes; Venous Thromboembolism; Warfarin	2013
Efficacy and safety outcomes of oral anticoagulants and antiplatelet drugs in the secondary prevention of venous thromboembolism: systematic review and network meta-analysis. BMJ (Clinical research ed.), 2013, Aug-30, Volume: 347 Topics: Anticoagulants; Aspirin; Benzimidazoles; beta-Alanine; Dabigatran; Hemorrhage; Humans; Morpholines; Platelet Aggregation Inhibitors; Pyrazoles; Pyridones; Recurrence; Rivaroxaban; Thiophenes; Venous Thromboembolism; Vitamin K	2013
Anticoagulant and antiplatelet medications encountered in emergency surgery patients: a review of reversal strategies. The journal of trauma and acute care surgery, 2013, Volume: 75, Issue:3 Topics: Anticoagulants; Aspirin; Benzimidazoles; Clopidogrel; Dabigatran; Emergencies; Enoxaparin; Fondaparinux; Heparin; Humans; Morpholines; Platelet Aggregation Inhibitors; Platelet Transfusion; Polysaccharides; Pyrazoles; Pyridines; Pyridones; Rivaroxaban; Surgical Procedures, Operative; Thiophenes; Ticlopidine; Warfarin	2013
Anticoagulation and antiplatelet therapy in acute coronary syndromes. Cleveland Clinic journal of medicine, 2014, Volume: 81, Issue:2 Topics: Acute Coronary Syndrome; Adenosine; Anticoagulants; Aspirin; Benzimidazoles; beta-Alanine; Clopidogrel; Dabigatran; Enoxaparin; Fondaparinux; Heparin; Hirudins; Humans; Morpholines; Peptide Fragments; Piperazines; Platelet Aggregation Inhibitors; Platelet Glycoprotein GPIIb-IIIa Complex; Polysaccharides; Prasugrel Hydrochloride; Pyrazoles; Pyridones; Recombinant Proteins; Rivaroxaban; Thiophenes; Ticagrelor; Ticlopidine; Warfarin	2014
Unanswered questions in patients with concurrent atrial fibrillation and acute coronary syndrome. The American journal of cardiology, 2014, Mar-01, Volume: 113, Issue:5 Topics: Acute Coronary Syndrome; Anticoagulants; Aspirin; Atrial Fibrillation; Clopidogrel; Comorbidity; Drug Therapy, Combination; Factor Xa Inhibitors; Humans; Morpholines; Percutaneous Coronary Intervention; Platelet Aggregation Inhibitors; Practice Guidelines as Topic; Pyrazoles; Pyridones; Risk Assessment; Rivaroxaban; Stroke; Thiophenes; Thrombosis; Ticlopidine	2014
[More with atrial fibrillation, anticoagulants since the coming of NOAK ]. Lakartidningen, 2015, Jan-06, Volume: 112 Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anticoagulants; Antithrombins; Aspirin; Atrial Fibrillation; Benzimidazoles; beta-Alanine; Cohort Studies; Dabigatran; Drug Prescriptions; Drug Utilization; Factor Xa Inhibitors; Female; Humans; Male; Middle Aged; Morpholines; Pyrazoles; Pyridones; Risk Assessment; Rivaroxaban; Thiophenes; Warfarin	2015
[Anticoagulant therapy in secondary prevention of coronary events]. Vnitrni lekarstvi, 2014, Volume: 60, Issue:12 Topics: Acute Coronary Syndrome; Administration, Oral; Anticoagulants; Aspirin; Benzimidazoles; beta-Alanine; Clinical Trials as Topic; Clopidogrel; Dabigatran; Hemorrhage; Humans; Morpholines; Myocardial Infarction; Piperazines; Platelet Aggregation Inhibitors; Prasugrel Hydrochloride; Pyrazoles; Pyridones; Rivaroxaban; Secondary Prevention; Thiophenes; Ticlopidine; Warfarin	2014
New-onset atrial fibrillation after recent coronary stenting: Warfarin or non-vitamin K-antagonist oral anticoagulants to be added to aspirin and clopidogrel? A viewpoint. International journal of cardiology, 2015, Oct-01, Volume: 196 Topics: Anticoagulants; Antithrombins; Aspirin; Atrial Fibrillation; Clopidogrel; Dabigatran; Drug Combinations; Factor Xa Inhibitors; Humans; Percutaneous Coronary Intervention; Platelet Aggregation Inhibitors; Pyrazoles; Pyridones; Stents; Thrombosis; Ticlopidine; Warfarin	2015
Evolving strategies to prevent stroke and thromboembolism in nonvalvular atrial fibrillation. Cleveland Clinic journal of medicine, 2015, Volume: 82, Issue:12 Suppl 2 Topics: Anticoagulants; Aspirin; Atrial Appendage; Atrial Fibrillation; Dabigatran; Equipment and Supplies; Hemorrhage; Humans; Ligation; Platelet Aggregation Inhibitors; Pyrazoles; Pyridones; Rivaroxaban; Stroke; Thromboembolism; Warfarin	2015
Stroke Prevention in Atrial Fibrillation in Patients With Chronic Kidney Disease. Circulation, 2016, Apr-12, Volume: 133, Issue:15 Topics: Aged; Anticoagulants; Aspirin; Atrial Fibrillation; Clinical Trials as Topic; Creatinine; Diabetes Complications; Drugs, Investigational; Europe; Female; Heart Failure; Hemorrhage; Humans; Hypertension; Myocardial Infarction; North America; Observational Studies as Topic; Pyrazoles; Pyridones; Registries; Renal Insufficiency, Chronic; Severity of Illness Index; Stroke; Tachycardia; Thrombophilia; Treatment Outcome; Warfarin	2016
A systematic review of anti-thrombotic therapy in epistaxis. Rhinology, 2016, 12-01, Volume: 54, Issue:4 Topics: Anticoagulants; Antifibrinolytic Agents; Aspirin; Clopidogrel; Dabigatran; Disease Management; Epistaxis; Humans; Platelet Aggregation Inhibitors; Pyrazoles; Pyridones; Risk Assessment; Rivaroxaban; Ticlopidine; Tranexamic Acid; Warfarin	2016
Effect of Apixaban on All-Cause Death in Patients with Atrial Fibrillation: a Meta-Analysis Based on Imputed Placebo Effect. Cardiovascular drugs and therapy, 2017, Volume: 31, Issue:3 Topics: Aged; Anticoagulants; Aspirin; Atrial Fibrillation; Cause of Death; Female; Fibrinolytic Agents; Humans; Male; Placebo Effect; Prospective Studies; Pyrazoles; Pyridones; Randomized Controlled Trials as Topic; Risk Factors; Stroke; Warfarin	2017
Low-Molecular-Weight Heparin and the Relative Risk of Surgical Site Bleeding Complications: Results of a Systematic Review and Meta-Analysis of Randomized Controlled Trials of Venous Thromboprophylaxis in Patients After Total Joint Arthroplasty. The Journal of arthroplasty, 2017, Volume: 32, Issue:9 Topics: Anticoagulants; Arthroplasty; Arthroplasty, Replacement, Knee; Aspirin; Dabigatran; Hemorrhage; Heparin, Low-Molecular-Weight; Humans; Incidence; Pyrazoles; Pyridones; Randomized Controlled Trials as Topic; Risk; Rivaroxaban; Treatment Outcome; Venous Thromboembolism; Warfarin	2017
The Efficacy and Safety of 3 Types of Interventions for Stroke Prevention in Patients With Cardiovascular and Cerebrovascular Diseases: A Network Meta-analysis. Clinical therapeutics, 2017, Volume: 39, Issue:7 Topics: Anticoagulants; Aspirin; Bayes Theorem; Cardiovascular Diseases; Clopidogrel; Dabigatran; Dipyridamole; Hemorrhage; Humans; Odds Ratio; Pyrazoles; Pyridines; Pyridones; Randomized Controlled Trials as Topic; Thiazoles; Ticlopidine; Treatment Outcome; Warfarin	2017
Effectiveness and Tolerability of Anticoagulants for Thromboprophylaxis after Major Joint Surgery: a Network Meta-Analysis. Cellular physiology and biochemistry : international journal of experimental cellular physiology, biochemistry, and pharmacology, 2017, Volume: 42, Issue:5 Topics: Anticoagulants; Aspirin; Databases, Factual; Hemorrhage; Heparin, Low-Molecular-Weight; Humans; Joint Diseases; Odds Ratio; Postoperative Complications; Pyrazoles; Pyridones; Venous Thromboembolism	2017
A systematic review of direct oral anticoagulant use in chronic kidney disease and dialysis patients with atrial fibrillation. Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association, 2019, 02-01, Volume: 34, Issue:2 Topics: Administration, Oral; Anticoagulants; Aspirin; Atrial Fibrillation; Dabigatran; Embolism; Glomerular Filtration Rate; Hemorrhage; Humans; Pyrazoles; Pyridines; Pyridones; Randomized Controlled Trials as Topic; Renal Dialysis; Renal Insufficiency, Chronic; Risk Factors; Rivaroxaban; Stroke; Thiazoles; Treatment Outcome; Warfarin	2019
Association of Intracranial Hemorrhage Risk With Non-Vitamin K Antagonist Oral Anticoagulant Use vs Aspirin Use: A Systematic Review and Meta-analysis. JAMA neurology, 2018, 12-01, Volume: 75, Issue:12 Topics: Anticoagulants; Aspirin; Dose-Response Relationship, Drug; Fibrinolytic Agents; Humans; Intracranial Hemorrhages; Pyrazoles; Pyridones; Rivaroxaban	2018
Direct oral anticoagulants for extended treatment of venous thromboembolism: insights from the EINSTEIN CHOICE study. Blood transfusion = Trasfusione del sangue, 2020, Volume: 18, Issue:1 Topics: Administration, Oral; Aged; Anticoagulants; Aspirin; Dabigatran; Glycosaminoglycans; Hemorrhage; Humans; Middle Aged; Pyrazoles; Pyridones; Recurrence; Risk Factors; Rivaroxaban; Treatment Outcome; Venous Thromboembolism; Vitamin K	2020
Venous thromboembolism in plastic surgery: the current state of evidence in risk assessment and chemoprophylactic options. Journal of plastic surgery and hand surgery, 2019, Volume: 53, Issue:6 Topics: Administration, Oral; Anticoagulants; Aspirin; Chemoprevention; Heparin, Low-Molecular-Weight; Humans; Incidence; Plastic Surgery Procedures; Postoperative Complications; Pyrazoles; Pyridones; Risk Assessment; Rivaroxaban; Venous Thromboembolism	2019
Antithrombotic regimen for patients with cardiac indication for dual antiplatelet therapy and anticoagulation: a meta-analysis of randomized trials. Coronary artery disease, 2020, Volume: 31, Issue:3 Topics: Acute Coronary Syndrome; Anticoagulants; Aspirin; Atrial Fibrillation; Clopidogrel; Dabigatran; Drug Therapy, Combination; Dual Anti-Platelet Therapy; Factor Xa Inhibitors; Hemorrhage; Humans; Percutaneous Coronary Intervention; Platelet Aggregation Inhibitors; Prasugrel Hydrochloride; Pyrazoles; Pyridones; Randomized Controlled Trials as Topic; Rivaroxaban; Stroke; Ticagrelor; Warfarin	2020
Drug interactions with apixaban: A systematic review of the literature and an analysis of VigiBase, the World Health Organization database of spontaneous safety reports. Pharmacology research & perspectives, 2020, Volume: 8, Issue:5 Topics: Adult; Adverse Drug Reaction Reporting Systems; Aged; Aged, 80 and over; Area Under Curve; Aspirin; ATP Binding Cassette Transporter, Subfamily B; Cytochrome P-450 CYP3A; Databases, Factual; Drug Interactions; Drug-Related Side Effects and Adverse Reactions; Factor Xa Inhibitors; Female; Gastrointestinal Hemorrhage; Hemostasis; Humans; Male; Middle Aged; Pharmacovigilance; Platelet Aggregation Inhibitors; Pyrazoles; Pyridones; Risk Assessment; Thromboembolism; World Health Organization	2020
Increased bleeding events with the addition of apixaban to the dual anti-platelet regimen for the treatment of patients with acute coronary syndrome: A meta-analysis. Medicine, 2021, Mar-26, Volume: 100, Issue:12 Topics: Acute Coronary Syndrome; Anticoagulants; Aspirin; Clopidogrel; Drug Therapy, Combination; Hemorrhage; Humans; Pyrazoles; Pyridones; Risk Factors	2021
Apixaban for Anticoagulation After Robotic Mitral Valve Repair. The Annals of thoracic surgery, 2023, Volume: 115, Issue:4 Topics: Aftercare; Anticoagulants; Aspirin; Atrial Fibrillation; Female; Hemorrhage; Humans; Male; Middle Aged; Mitral Valve; Patient Discharge; Pyridones; Robotic Surgical Procedures; Stroke; Thromboembolism; Treatment Outcome; Warfarin	2023

Trials

31 trial(s) available for aspirin and apixaban

Article	Year
Apixaban, an oral, direct, selective factor Xa inhibitor, in combination with antiplatelet therapy after acute coronary syndrome: results of the Apixaban for Prevention of Acute Ischemic and Safety Events (APPRAISE) trial. Circulation, 2009, Jun-09, Volume: 119, Issue:22 Topics: Acute Coronary Syndrome; Adolescent; Adult; Aged; Aged, 80 and over; Aspirin; Clopidogrel; Dose-Response Relationship, Drug; Double-Blind Method; Drug Therapy, Combination; Factor Xa Inhibitors; Female; Hemorrhage; Humans; Male; Middle Aged; Myocardial Ischemia; Platelet Aggregation Inhibitors; Pyrazoles; Pyridones; Ticlopidine; Young Adult	2009
Rationale and design of AVERROES: apixaban versus acetylsalicylic acid to prevent stroke in atrial fibrillation patients who have failed or are unsuitable for vitamin K antagonist treatment. American heart journal, 2010, Volume: 159, Issue:3 Topics: Aged; Aged, 80 and over; Aspirin; Atrial Fibrillation; Double-Blind Method; Drug Administration Schedule; Fibrinolytic Agents; Hemorrhage; Humans; Middle Aged; Platelet Aggregation Inhibitors; Pyrazoles; Pyridones; Research Design; Retreatment; Stroke; Treatment Failure; Vitamin K; Warfarin	2010
Apixaban in patients with atrial fibrillation. The New England journal of medicine, 2011, Mar-03, Volume: 364, Issue:9 Topics: Aged; Aged, 80 and over; Aspirin; Atrial Fibrillation; Double-Blind Method; Embolism; Factor Xa Inhibitors; Female; Fibrinolytic Agents; Hemorrhage; Humans; Male; Middle Aged; Proportional Hazards Models; Pyrazoles; Pyridones; Risk Factors; Stroke	2011
Apixaban with antiplatelet therapy after acute coronary syndrome. The New England journal of medicine, 2011, Aug-25, Volume: 365, Issue:8 Topics: Acute Coronary Syndrome; Aged; Angina, Unstable; Aspirin; Double-Blind Method; Drug Therapy, Combination; Factor Xa Inhibitors; Female; Hemorrhage; Humans; Kaplan-Meier Estimate; Male; Middle Aged; Myocardial Infarction; Platelet Aggregation Inhibitors; Proportional Hazards Models; Pyrazoles; Pyridones; Stroke; Treatment Outcome	2011
Apixaban versus aspirin in patients with atrial fibrillation and previous stroke or transient ischaemic attack: a predefined subgroup analysis from AVERROES, a randomised trial. The Lancet. Neurology, 2012, Volume: 11, Issue:3 Topics: Aged; Aged, 80 and over; Aspirin; Atrial Fibrillation; Female; Fibrinolytic Agents; Humans; Ischemic Attack, Transient; Male; Middle Aged; Pyrazoles; Pyridones; Stroke; Treatment Outcome	2012
Stroke risk and efficacy of apixaban in atrial fibrillation patients with moderate chronic kidney disease. Journal of stroke and cerebrovascular diseases : the official journal of National Stroke Association, 2012, Volume: 21, Issue:6 Topics: Aged; Aspirin; Atrial Fibrillation; Biomarkers; Chi-Square Distribution; Creatinine; Double-Blind Method; Embolism; Female; Fibrinolytic Agents; Glomerular Filtration Rate; Hemorrhage; Humans; Kidney; Male; Proportional Hazards Models; Pyrazoles; Pyridones; Renal Insufficiency, Chronic; Risk Assessment; Risk Factors; Severity of Illness Index; Stroke; Treatment Outcome	2012
Bleeding during treatment with aspirin versus apixaban in patients with atrial fibrillation unsuitable for warfarin: the apixaban versus acetylsalicylic acid to prevent stroke in atrial fibrillation patients who have failed or are unsuitable for vitamin K Stroke, 2012, Volume: 43, Issue:12 Topics: Aged; Anticoagulants; Aspirin; Atrial Fibrillation; Brain Ischemia; Cerebral Hemorrhage; Contraindications; Female; Fibrinolytic Agents; Follow-Up Studies; Humans; Male; Platelet Aggregation Inhibitors; Pyrazoles; Pyridones; Risk Factors; Stroke; Vitamin K; Warfarin	2012
Modification of outcomes with aspirin or apixaban in relation to CHADS(2) and CHA(2)DS(2)-VASc scores in patients with atrial fibrillation: a secondary analysis of the AVERROES study. Circulation. Arrhythmia and electrophysiology, 2013, Volume: 6, Issue:1 Topics: Aged; Aspirin; Atrial Fibrillation; Brain Ischemia; Female; Fibrinolytic Agents; Health Status Indicators; Hemorrhage; Humans; Male; Middle Aged; Multivariate Analysis; Proportional Hazards Models; Pyrazoles; Pyridones; Risk Assessment; Risk Factors; Stroke; Treatment Outcome	2013
Mixed treatment comparison meta-analysis of aspirin, warfarin, and new anticoagulants for stroke prevention in patients with nonvalvular atrial fibrillation. Clinical therapeutics, 2013, Volume: 35, Issue:7 Topics: Anticoagulants; Aspirin; Atrial Fibrillation; Benzimidazoles; beta-Alanine; Dabigatran; Data Interpretation, Statistical; Databases, Bibliographic; Double-Blind Method; Hemorrhage; Humans; Morpholines; Pyrazoles; Pyridones; Rivaroxaban; Stroke; Thiophenes; Warfarin	2013
Comparison of Medical Costs of Patients With Atrial Fibrillation Unsuitable for Warfarin Treatment With Apixaban or Aspirin Based on AVERROES Trial. Clinical and applied thrombosis/hemostasis : official journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis, 2015, Volume: 21, Issue:3 Topics: Anticoagulants; Aspirin; Atrial Fibrillation; Costs and Cost Analysis; Female; Humans; Male; Pyrazoles; Pyridones; Warfarin	2015
Apixaban vs. warfarin with concomitant aspirin in patients with atrial fibrillation: insights from the ARISTOTLE trial. European heart journal, 2014, Volume: 35, Issue:4 Topics: Administration, Oral; Aged; Anticoagulants; Aspirin; Atrial Fibrillation; Double-Blind Method; Drug Therapy, Combination; Embolism; Female; Fibrinolytic Agents; Hemorrhage; Humans; Male; Middle Aged; Pyrazoles; Pyridones; Stroke; Treatment Outcome; Warfarin	2014
Efficacy and safety of apixaban compared with aspirin in patients who previously tried but failed treatment with vitamin K antagonists: results from the AVERROES trial. European heart journal, 2014, Jul-21, Volume: 35, Issue:28 Topics: Aged; Aspirin; Atrial Fibrillation; Double-Blind Method; Drug Administration Schedule; Factor Xa Inhibitors; Female; Fibrinolytic Agents; Hemorrhage; Humans; Male; Pyrazoles; Pyridones; Risk Factors; Stroke; Treatment Outcome; Vitamin K	2014
Modification of outcomes with aspirin or apixaban in relation to female and male sex in patients with atrial fibrillation: a secondary analysis of the AVERROES study. Stroke, 2014, Volume: 45, Issue:7 Topics: Age Factors; Aged; Aspirin; Atrial Fibrillation; Brain Ischemia; Cerebral Hemorrhage; Comorbidity; Double-Blind Method; Female; Fibrinolytic Agents; Follow-Up Studies; Humans; Male; Pyrazoles; Pyridones; Sex Factors; Stroke; Treatment Outcome	2014
Initial 3-weeks' Apixaban Versus Dual-antiplatelet Therapy (Clopidogrel and Aspirin) followed by Clopidogrel alone in high-risk patients with Acute Non-Disabling Cerebrovascular Events (ADANCE): study protocol for a randomized controlled trial. Clinical drug investigation, 2014, Volume: 34, Issue:11 Topics: Administration, Oral; Adolescent; Adult; Aspirin; Clopidogrel; Double-Blind Method; Drug Administration Schedule; Drug Therapy, Combination; Endpoint Determination; Female; Humans; Male; Platelet Aggregation Inhibitors; Pyrazoles; Pyridones; Stroke; Ticlopidine; Time Factors; Treatment Outcome; Young Adult	2014
Clinical and Economic Implications of Apixaban Versus Aspirin in the Low-Risk Nonvalvular Atrial Fibrillation Patients. Stroke, 2015, Volume: 46, Issue:10 Topics: Aged; Aspirin; Atrial Fibrillation; Cost-Benefit Analysis; Factor Xa Inhibitors; Female; Hemorrhage; Humans; Male; Markov Chains; Middle Aged; Platelet Aggregation Inhibitors; Pyrazoles; Pyridones; Quality-Adjusted Life Years; Risk Factors; Stroke	2015
Efficacy and safety of apixaban compared with aspirin in the elderly: a subgroup analysis from the AVERROES trial. Age and ageing, 2016, Volume: 45, Issue:1 Topics: Age Factors; Aged; Aged, 80 and over; Anticoagulants; Aspirin; Atrial Fibrillation; Factor Xa Inhibitors; Female; Hemorrhage; Humans; Male; Prospective Studies; Pyrazoles; Pyridones; Risk Factors; Stroke; Time Factors; Treatment Outcome	2016
Rationale and design of the SAFE-A study: SAFety and Effectiveness trial of Apixaban use in association with dual antiplatelet therapy in patients with atrial fibrillation undergoing percutaneous coronary intervention. Journal of cardiology, 2017, Volume: 69, Issue:4 Topics: Aspirin; Atrial Fibrillation; Blood Transfusion; Clopidogrel; Drug Therapy, Combination; Drug-Eluting Stents; Factor Xa Inhibitors; Female; Hemorrhage; Humans; Male; Middle Aged; Myocardial Infarction; Percutaneous Coronary Intervention; Platelet Aggregation Inhibitors; Prasugrel Hydrochloride; Prospective Studies; Purinergic P2Y Receptor Antagonists; Pyrazoles; Pyridones; Stroke; Ticlopidine	2017
Effect of apixaban on brain infarction and microbleeds: AVERROES-MRI assessment study. American heart journal, 2016, Volume: 178 Topics: Aged; Aspirin; Atrial Fibrillation; Brain; Brain Infarction; Cerebral Hemorrhage; Embolism; Factor Xa Inhibitors; Female; Humans; Longitudinal Studies; Magnetic Resonance Imaging; Male; Middle Aged; Platelet Aggregation Inhibitors; Proportional Hazards Models; Pyrazoles; Pyridones	2016
Apixaban for treatment of embolic stroke of undetermined source (ATTICUS randomized trial): Rationale and study design. International journal of stroke : official journal of the International Stroke Society, 2017, Volume: 12, Issue:9 Topics: Aspirin; Brain; Embolism; Factor Xa Inhibitors; Fibrinolytic Agents; Humans; Pyrazoles; Pyridones; Research Design; Secondary Prevention; Stroke	2017
Intracranial hemorrhage in patients with atrial fibrillation receiving anticoagulation therapy. Blood, 2017, 06-01, Volume: 129, Issue:22 Topics: Aged; Aged, 80 and over; Anticoagulants; Aspirin; Atrial Fibrillation; Factor Xa Inhibitors; Female; Humans; International Normalized Ratio; Intracranial Hemorrhages; Kaplan-Meier Estimate; Male; Middle Aged; Pyrazoles; Pyridones; Warfarin	2017
Percutaneous coronary intervention and antiplatelet therapy in patients with atrial fibrillation receiving apixaban or warfarin: Insights from the ARISTOTLE trial. American heart journal, 2018, Volume: 197 Topics: Aged; Anticoagulants; Aspirin; Atrial Fibrillation; Coronary Artery Disease; Drug Monitoring; Female; Hemorrhage; Humans; International Normalized Ratio; Male; Middle Aged; Myocardial Infarction; Outcome Assessment, Health Care; Percutaneous Coronary Intervention; Platelet Aggregation Inhibitors; Postoperative Complications; Proportional Hazards Models; Pyrazoles; Pyridones; Stroke; Warfarin	2018
An open-Label, 2 × 2 factorial, randomized controlled trial to evaluate the safety of apixaban vs. vitamin K antagonist and aspirin vs. placebo in patients with atrial fibrillation and acute coronary syndrome and/or percutaneous coronary intervention: Rat American heart journal, 2018, Volume: 200 Topics: Acute Coronary Syndrome; Adult; Aged; Anticoagulants; Aspirin; Atrial Fibrillation; Female; Hemorrhage; Humans; Male; Middle Aged; Patient Selection; Percutaneous Coronary Intervention; Platelet Aggregation Inhibitors; Pyrazoles; Pyridones; Risk Factors; Stroke; Treatment Outcome; Warfarin	2018
Antithrombotic Therapy after Acute Coronary Syndrome or PCI in Atrial Fibrillation. The New England journal of medicine, 2019, 04-18, Volume: 380, Issue:16 Topics: Acute Coronary Syndrome; Aged; Aged, 80 and over; Anticoagulants; Aspirin; Atrial Fibrillation; Double-Blind Method; Drug Therapy, Combination; Factor Xa Inhibitors; Female; Hemorrhage; Humans; Male; Middle Aged; Percutaneous Coronary Intervention; Platelet Aggregation Inhibitors; Purinergic P2Y Receptor Antagonists; Pyrazoles; Pyridones; Vitamin K	2019
What are the difficulties in conducting randomised controlled trials of thromboprophylaxis in myeloma patients and how can we address these? Lessons from apixaban versus LMWH or aspirin as thromboprophylaxis in newly diagnosed multiple myeloma (TiMM) feas Journal of thrombosis and thrombolysis, 2019, Volume: 48, Issue:2 Topics: Aged; Aspirin; Clinical Trial Protocols as Topic; Feasibility Studies; Female; Focus Groups; Heparin, Low-Molecular-Weight; Humans; Male; Middle Aged; Multiple Myeloma; Pyrazoles; Pyridones; Randomized Controlled Trials as Topic; Risk Assessment; Venous Thromboembolism	2019
Clinical consequences of bleeding among individuals with a recent acute coronary syndrome: Insights from the APPRAISE-2 trial. American heart journal, 2019, Volume: 215 Topics: Aged; Aspirin; Double-Blind Method; Drug Interactions; Drug Therapy, Combination; Factor Xa Inhibitors; Female; Hemorrhage; Humans; Male; Middle Aged; Myocardial Infarction; Outcome and Process Assessment, Health Care; Platelet Aggregation Inhibitors; Proportional Hazards Models; Pyrazoles; Pyridines; Pyridones; Risk Assessment; Risk Factors; Thrombolytic Therapy	2019
Antithrombotic Therapy in Patients With Atrial Fibrillation and Acute Coronary Syndrome Treated Medically or With Percutaneous Coronary Intervention or Undergoing Elective Percutaneous Coronary Intervention: Insights From the AUGUSTUS Trial. Circulation, 2019, 12-03, Volume: 140, Issue:23 Topics: Acute Coronary Syndrome; Aged; Anticoagulants; Aspirin; Atrial Fibrillation; Cardiovascular Agents; Combined Modality Therapy; Disease Management; Drug Therapy, Combination; Elective Surgical Procedures; Female; Fibrinolytic Agents; Hemorrhage; Hospitalization; Humans; Male; Middle Aged; Percutaneous Coronary Intervention; Platelet Aggregation Inhibitors; Proportional Hazards Models; Prospective Studies; Purinergic P2Y Receptor Antagonists; Pyrazoles; Pyridones; Treatment Outcome; Vitamin K	2019
Stent Thrombosis in Patients With Atrial Fibrillation Undergoing Coronary Stenting in the AUGUSTUS Trial. Circulation, 2020, 03-03, Volume: 141, Issue:9 Topics: Anticoagulants; Aspirin; Atrial Fibrillation; Coronary Artery Disease; Coronary Thrombosis; Factor Xa Inhibitors; Fibrinolytic Agents; Humans; Percutaneous Coronary Intervention; Pyrazoles; Pyridones; Risk Factors; Stents; Time Factors; Treatment Outcome; Vitamin K	2020
Rationale and design for the study Apixaban versus ClopidoGRel on a background of aspirin in patient undergoing InfraPoPliteal angioplasty for critical limb ischemia: AGRIPPA trial. American heart journal, 2020, Volume: 227 Topics: Angioplasty; Aspirin; Clopidogrel; Critical Illness; Factor Xa Inhibitors; Humans; Ischemia; Leg; Multicenter Studies as Topic; Peripheral Arterial Disease; Platelet Aggregation Inhibitors; Popliteal Artery; Postoperative Complications; Proof of Concept Study; Prospective Studies; Pyrazoles; Pyridones; Randomized Controlled Trials as Topic; Thrombosis	2020
Effect of Antithrombotic Therapy on Clinical Outcomes in Outpatients With Clinically Stable Symptomatic COVID-19: The ACTIV-4B Randomized Clinical Trial. JAMA, 2021, 11-02, Volume: 326, Issue:17 Topics: Adult; Aspirin; COVID-19; COVID-19 Drug Treatment; Dose-Response Relationship, Drug; Double-Blind Method; Early Termination of Clinical Trials; Factor Xa Inhibitors; Female; Hemorrhage; Hospitalization; Humans; Male; Middle Aged; Platelet Aggregation Inhibitors; Pyrazoles; Pyridones; Thrombosis	2021
Impact of prior oral anticoagulant use and outcomes on patients from secondary analysis in the AUGUSTUS trial. Open heart, 2022, Volume: 9, Issue:1 Topics: Acute Coronary Syndrome; Aspirin; Atrial Fibrillation; Factor Xa Inhibitors; Female; Hemorrhage; Humans; Ischemia; Male; Medication Therapy Management; Middle Aged; Outcome and Process Assessment, Health Care; Percutaneous Coronary Intervention; Platelet Aggregation Inhibitors; Preoperative Period; Pyrazoles; Pyridones; Vitamin K	2022
Apixaban or Warfarin and Aspirin or Placebo After Acute Coronary Syndrome or Percutaneous Coronary Intervention in Patients With Atrial Fibrillation and Prior Stroke: A Post Hoc Analysis From the AUGUSTUS Trial. JAMA cardiology, 2022, 07-01, Volume: 7, Issue:7 Topics: Acute Coronary Syndrome; Anticoagulants; Aspirin; Atrial Fibrillation; Fibrinolytic Agents; Hemorrhage; Humans; Ischemic Attack, Transient; Percutaneous Coronary Intervention; Prospective Studies; Pyrazoles; Pyridones; Stroke; Thromboembolism; Warfarin	2022

Other Studies

61 other study(ies) available for aspirin and apixaban

Article	Year
In vivo quantitative high-throughput screening for drug discovery and comparative toxicology. Disease models & mechanisms, 2023, 03-01, Volume: 16, Issue:3 Topics: Animals; Caenorhabditis elegans; Drug Discovery; High-Throughput Screening Assays; Humans; Proteomics; Small Molecule Libraries	2023
Arterial antithrombotic and bleeding time effects of apixaban, a direct factor Xa inhibitor, in combination with antiplatelet therapy in rabbits. Journal of thrombosis and haemostasis : JTH, 2008, Volume: 6, Issue:10 Topics: Animals; Aspirin; Bleeding Time; Carotid Artery Thrombosis; Clopidogrel; Drug Therapy, Combination; Factor Xa Inhibitors; Fibrinolytic Agents; Platelet Aggregation Inhibitors; Pyrazoles; Pyridones; Rabbits; Ticlopidine; Treatment Outcome	2008
The unmet need of patients with atrial fibrillation: AVERROES and the novel oral anticoagulants. International journal of stroke : official journal of the International Stroke Society, 2011, Volume: 6, Issue:3 Topics: Angiotensin II Type 1 Receptor Blockers; Anticoagulants; Aspirin; Atrial Fibrillation; Biphenyl Compounds; Clinical Trials, Phase III as Topic; Clopidogrel; Factor Xa Inhibitors; Fibrinolytic Agents; Humans; Intracranial Hemorrhages; Irbesartan; Platelet Aggregation Inhibitors; Pyrazoles; Pyridones; Stroke; Tetrazoles; Ticlopidine	2011
Apixaban in patients with atrial fibrillation. The New England journal of medicine, 2011, 06-16, Volume: 364, Issue:24 Topics: Aspirin; Atrial Fibrillation; Fibrinolytic Agents; Humans; Pyrazoles; Pyridones; Stroke; Warfarin	2011
Apixaban in patients with atrial fibrillation. The New England journal of medicine, 2011, 06-16, Volume: 364, Issue:24 Topics: Anti-Inflammatory Agents, Non-Steroidal; Anticoagulants; Aspirin; Atrial Fibrillation; Brain Ischemia; Drug Interactions; Embolism; Fibrinolytic Agents; Humans; Pyrazoles; Pyridones; Stroke	2011
[The AVERROES study]. Giornale italiano di cardiologia (2006), 2011, Volume: 12, Issue:9 Topics: Aspirin; Atrial Fibrillation; Follow-Up Studies; Humans; Italy; Platelet Aggregation Inhibitors; Pyrazoles; Pyridones; Randomized Controlled Trials as Topic; Research Design; Stroke; Survival Analysis; Thromboembolism; Treatment Outcome	2011
Prevention of stroke in atrial fibrillation: cautious optimism. The Lancet. Neurology, 2012, Volume: 11, Issue:3 Topics: Aspirin; Atrial Fibrillation; Female; Fibrinolytic Agents; Humans; Ischemic Attack, Transient; Male; Pyrazoles; Pyridones; Stroke	2012
Cost-effectiveness of apixaban compared with aspirin for stroke prevention in atrial fibrillation among patients unsuitable for warfarin. Circulation. Cardiovascular quality and outcomes, 2012, Jul-01, Volume: 5, Issue:4 Topics: Aged; Anticoagulants; Aspirin; Atrial Fibrillation; Contraindications; Cost-Benefit Analysis; Drug Costs; Hemorrhage; Humans; Markov Chains; Medicare; Models, Economic; Primary Prevention; Probability; Pyrazoles; Pyridones; Quality-Adjusted Life Years; Risk Assessment; Risk Factors; Stroke; Time Factors; Treatment Outcome; United States; Warfarin	2012
[Atrial fibrillation. Apixaban reduces stroke risk]. MMW Fortschritte der Medizin, 2013, Mar-07, Volume: 155, Issue:4 Topics: Adult; Aged; Anticoagulants; Aspirin; Atrial Fibrillation; Clinical Trials, Phase III as Topic; Drug Approval; Embolism; Germany; Humans; Middle Aged; Pyrazoles; Pyridones; Randomized Controlled Trials as Topic; Stroke; Warfarin	2013
Contra: "New oral anticoagulants should not be used as 1st choice for secondary stroke prevention in atrial fibrillation". Thrombosis and haemostasis, 2013, Volume: 110, Issue:3 Topics: Aged; Aged, 80 and over; Anticoagulants; Aspirin; Atrial Fibrillation; Benzimidazoles; beta-Alanine; Dabigatran; Hemorrhage; Humans; Middle Aged; Morpholines; Patient Safety; Pyrazoles; Pyridones; Randomized Controlled Trials as Topic; Rivaroxaban; Secondary Prevention; Stroke; Thiophenes; Warfarin	2013
Pro: "The novel oral anticoagulants should be used as 1st choice for secondary prevention in patients with atrial fibrillation.". Thrombosis and haemostasis, 2013, Volume: 110, Issue:3 Topics: Aged; Anticoagulants; Aspirin; Atrial Fibrillation; Benzimidazoles; beta-Alanine; Dabigatran; Diabetes Complications; Female; Hemorrhage; Humans; Hypertension; Male; Middle Aged; Morpholines; Pyrazoles; Pyridones; Randomized Controlled Trials as Topic; Rivaroxaban; Secondary Prevention; Stroke; Thiophenes; Warfarin	2013
[From apixaban to aspirin in the prevention of recurrent venous thromboembolism]. Investigacion clinica, 2013, Volume: 54, Issue:3 Topics: Anticoagulants; Antithrombins; Aspirin; Clinical Trials as Topic; Factor Xa Inhibitors; Heparin, Low-Molecular-Weight; Humans; Multicenter Studies as Topic; Pyrazoles; Pyridones; Recurrence; Thromboembolism; Thrombophilia; Venous Thrombosis; Vitamin K	2013
Cost-effectiveness of apixaban vs. current standard of care for stroke prevention in patients with atrial fibrillation. European heart journal, 2014, Jul-21, Volume: 35, Issue:28 Topics: Aged; Anticoagulants; Aspirin; Atrial Fibrillation; Cost-Benefit Analysis; Drug Costs; Factor Xa Inhibitors; Female; Hemorrhage; Hospitalization; Humans; Male; Markov Chains; Middle Aged; Multicenter Studies as Topic; Pyrazoles; Pyridones; Quality-Adjusted Life Years; Randomized Controlled Trials as Topic; Risk Factors; Stroke; Vitamin K; Warfarin	2014
Triple antithrombotic therapy: risky but sometimes necessary. Revista espanola de cardiologia (English ed.), 2014, Volume: 67, Issue:3 Topics: Anticoagulants; Aspirin; Benzimidazoles; beta-Alanine; Clinical Trials as Topic; Clopidogrel; Dabigatran; Drug Therapy, Combination; Humans; Morpholines; Piperazines; Platelet Aggregation Inhibitors; Prasugrel Hydrochloride; Pyrazoles; Pyridones; Rivaroxaban; Thiophenes; Ticlopidine; Vitamin K	2014
Stroke prevention in patients with atrial fibrillation in France: comparative cost-effectiveness of new oral anticoagulants (apixaban, dabigatran, and rivaroxaban), warfarin, and aspirin. Journal of medical economics, 2014, Volume: 17, Issue:8 Topics: Anticoagulants; Antithrombins; Aspirin; Atrial Fibrillation; Benzimidazoles; beta-Alanine; Comparative Effectiveness Research; Cost-Benefit Analysis; Dabigatran; Factor Xa Inhibitors; Female; France; Humans; Male; Morpholines; Pyrazoles; Pyridones; Quality-Adjusted Life Years; Rivaroxaban; Stroke; Thiophenes; Warfarin	2014
Cost-effectiveness of apixaban versus warfarin and aspirin in Sweden for stroke prevention in patients with atrial fibrillation. Thrombosis research, 2014, Volume: 134, Issue:2 Topics: Aged; Aged, 80 and over; Anticoagulants; Aspirin; Atrial Fibrillation; Cost-Benefit Analysis; Female; Humans; Male; Middle Aged; Pyrazoles; Pyridones; Stroke; Sweden; Warfarin	2014
Cost effectiveness of apixaban versus aspirin for stroke prevention in patients with non-valvular atrial fibrillation in Belgium. Clinical drug investigation, 2014, Volume: 34, Issue:10 Topics: Aged; Aspirin; Atrial Fibrillation; Belgium; Cost-Benefit Analysis; Factor Xa Inhibitors; Female; Hemorrhage; Humans; Male; Markov Chains; Platelet Aggregation Inhibitors; Pyrazoles; Pyridones; Quality-Adjusted Life Years; Stroke	2014
Diffuse alveolar hemorrhage secondary to apixaban administration. Chest, 2014, Volume: 146, Issue:3 Topics: Aged; Aspirin; Atrial Fibrillation; Continuous Positive Airway Pressure; Female; Fibrinolytic Agents; Hemorrhage; Humans; Lung Diseases; Pyrazoles; Pyridones; Treatment Outcome	2014
Reviewing a clinical decision aid for the selection of anticoagulation treatment in patients with nonvalvular atrial fibrillation: applications in a US managed care health plan database. Clinical therapeutics, 2014, Nov-01, Volume: 36, Issue:11 Topics: Aged; Anticoagulants; Aspirin; Atrial Fibrillation; Dabigatran; Databases, Factual; Decision Support Techniques; Female; Hemorrhage; Humans; Male; Managed Care Programs; Middle Aged; Pyrazoles; Pyridones; Retrospective Studies; Risk Factors; Stroke; United States	2014
Underutilisation of Guideline-based Therapy Primary Prevention among Patients Presenting with AF-related Ischaemic Stroke. Annals of the Academy of Medicine, Singapore, 2015, Volume: 44, Issue:7 Topics: Aged; Aged, 80 and over; Anticoagulants; Aspirin; Atrial Fibrillation; Brain Ischemia; Clopidogrel; Dabigatran; Dipyridamole; Female; Guideline Adherence; Humans; Male; Middle Aged; Platelet Aggregation Inhibitors; Practice Guidelines as Topic; Primary Prevention; Pyrazoles; Pyridones; Rivaroxaban; Stroke; Ticlopidine; Warfarin	2015
Comparison of treatment persistence with different oral anticoagulants in patients with atrial fibrillation. European journal of clinical pharmacology, 2016, Volume: 72, Issue:3 Topics: Administration, Oral; Aged; Aged, 80 and over; Anticoagulants; Aspirin; Atrial Fibrillation; Dabigatran; Drug Substitution; Female; Humans; Male; Medication Adherence; Pyrazoles; Pyridones; Rivaroxaban; Warfarin	2016
Cost effectiveness of left atrial appendage closure with the Watchman device for atrial fibrillation patients with absolute contraindications to warfarin. Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology, 2016, Volume: 18, Issue:7 Topics: Anticoagulants; Aspirin; Atrial Appendage; Atrial Fibrillation; Cardiac Surgical Procedures; Clopidogrel; Contraindications; Cost-Benefit Analysis; Germany; Humans; Markov Chains; Models, Theoretical; Pyrazoles; Pyridones; Quality of Life; Quality-Adjusted Life Years; Stroke; Ticlopidine; Time Factors; Treatment Outcome; Warfarin	2016
Adoption of direct oral anticoagulants for stroke prevention in atrial fibrillation. Internal medicine journal, 2016, Volume: 46, Issue:7 Topics: Administration, Oral; Age Factors; Aged; Anticoagulants; Aspirin; Atrial Fibrillation; Atrial Flutter; Australia; Dabigatran; Drug Prescriptions; Drug Therapy, Combination; Glomerular Filtration Rate; Humans; Pyrazoles; Pyridones; Retrospective Studies; Risk Factors; Rivaroxaban; Severity of Illness Index; Stroke; Warfarin	2016
Evaluation of Dose-Reduced Direct Oral Anticoagulant Therapy. The American journal of medicine, 2016, Volume: 129, Issue:11 Topics: Aged; Aged, 80 and over; Antithrombins; Aspirin; Atrial Fibrillation; Comorbidity; Creatinine; Dabigatran; Dose-Response Relationship, Drug; Factor Xa Inhibitors; Female; Hemorrhage; Humans; Male; Middle Aged; Platelet Aggregation Inhibitors; Pyrazoles; Pyridones; Renal Insufficiency; Retrospective Studies; Rivaroxaban; Stroke; Venous Thromboembolism	2016
[Acute subdural hematoma in a patient in treatment with apixaban and acetylsalicylic acid]. Medicina clinica, 2016, Oct-07, Volume: 147, Issue:7 Topics: Aged, 80 and over; Aspirin; Atrial Fibrillation; Drug Therapy, Combination; Factor Xa Inhibitors; Hematoma, Subdural, Acute; Humans; Male; Platelet Aggregation Inhibitors; Pyrazoles; Pyridones	2016
Safety ad efficacy of direct oral anticoagulants for extended treatment of venous thromboembolism. Internal and emergency medicine, 2016, Volume: 11, Issue:7 Topics: Administration, Oral; Anticoagulants; Aspirin; Dabigatran; Humans; Italy; Pyrazoles; Pyridones; Rivaroxaban; Time Factors; Venous Thromboembolism; Vitamin K; Warfarin	2016
Clinical and Cost Effectiveness of Apixaban Compared to Aspirin in Patients with Atrial Fibrillation: An Australian Perspective. Applied health economics and health policy, 2017, Volume: 15, Issue:3 Topics: Adult; Aged; Aged, 80 and over; Aspirin; Atrial Fibrillation; Australia; Cost-Benefit Analysis; Female; Fibrinolytic Agents; Humans; Male; Middle Aged; Pyrazoles; Pyridones	2017
Cost Effectiveness of Apixaban versus Warfarin or Aspirin for Stroke Prevention in Patients with Atrial Fibrillation: A Greek Perspective. American journal of cardiovascular drugs : drugs, devices, and other interventions, 2017, Volume: 17, Issue:2 Topics: Anticoagulants; Aspirin; Atrial Fibrillation; Computer Simulation; Cost-Benefit Analysis; Drug Costs; Female; Greece; Humans; Male; Models, Theoretical; Platelet Aggregation Inhibitors; Pyrazoles; Pyridones; Risk; Stroke; Warfarin	2017
Novel oral anticoagulants and trauma: The results of a prospective American Association for the Surgery of Trauma Multi-Institutional Trial. The journal of trauma and acute care surgery, 2017, Volume: 82, Issue:5 Topics: Administration, Oral; Aged; Anticoagulants; Aspirin; Clopidogrel; Dabigatran; Female; Humans; Injury Severity Score; Intracranial Hemorrhages; Male; Platelet Aggregation Inhibitors; Prospective Studies; Pyrazoles; Pyridones; Rivaroxaban; Ticlopidine; Trauma Centers; Warfarin; Wounds and Injuries; Wounds, Nonpenetrating	2017
A comparison between vitamin K antagonists and new oral anticoagulants. British journal of clinical pharmacology, 2017, Volume: 83, Issue:11 Topics: Administration, Oral; Anticoagulants; Aspirin; Atrial Fibrillation; Clinical Trials, Phase III as Topic; Dabigatran; Humans; Intracranial Hemorrhages; Pyrazoles; Pyridines; Pyridones; Rivaroxaban; Stroke; Thiazoles; Vitamin K; Warfarin	2017
Severity of Gastrointestinal Bleeding in Patients Treated with Direct-Acting Oral Anticoagulants. The American journal of medicine, 2018, Volume: 131, Issue:5 Topics: Administration, Oral; Aged; Anticoagulants; Arteriovenous Malformations; Aspirin; Blood Transfusion; Case-Control Studies; Dabigatran; Diverticulum; Endoscopy, Gastrointestinal; Female; Gastrointestinal Hemorrhage; Hemorrhoids; Hospitalization; Humans; Male; Middle Aged; Peptic Ulcer; Platelet Aggregation Inhibitors; Pyrazoles; Pyridones; Retrospective Studies; Rivaroxaban; Warfarin	2018
WATCHMAN device-related thrombus successfully treated with apixaban: A case report. Medicine, 2017, Volume: 96, Issue:47 Topics: Aged; Anticoagulants; Aspirin; Atrial Appendage; Atrial Fibrillation; Clopidogrel; Factor Xa Inhibitors; Humans; Male; Prostheses and Implants; Pyrazoles; Pyridones; Thrombosis; Ticlopidine	2017
Differences in Reported Outcomes in Industry-Funded vs Nonfunded Studies Assessing Thromboprophylaxis After Total Joint Arthroplasty. The Journal of arthroplasty, 2018, Volume: 33, Issue:11 Topics: Aged; Anticoagulants; Arthroplasty, Replacement, Hip; Arthroplasty, Replacement, Knee; Aspirin; Conflict of Interest; Dabigatran; Enoxaparin; Female; Fondaparinux; Health Care Sector; Hemorrhage; Humans; Male; Pulmonary Embolism; Pyrazoles; Pyridones; Rivaroxaban; Venous Thromboembolism; Warfarin	2018
Novel oral anticoagulants in primary care in patients with atrial fibrillation: a cross-sectional comparison before and after their introduction. BMC family practice, 2018, 07-18, Volume: 19, Issue:1 Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anticoagulants; Aspirin; Atrial Fibrillation; Cross-Sectional Studies; Dabigatran; Female; Germany; Humans; Male; Middle Aged; Phenprocoumon; Platelet Aggregation Inhibitors; Primary Health Care; Pyrazoles; Pyridones; Retrospective Studies; Rivaroxaban; Stroke; Young Adult	2018
Stroke prevention in atrial fibrillation: Closing the gap. American heart journal, 2019, Volume: 210 Topics: Administration, Oral; Anticoagulants; Aspirin; Atrial Fibrillation; Dabigatran; Health Services Misuse; Hemorrhage; Humans; International Normalized Ratio; Pyrazoles; Pyridines; Pyridones; Rivaroxaban; Septal Occluder Device; Stroke; Thiazoles; Warfarin	2019
Critical appraisal of the AUGUSTUS trial. European heart journal. Cardiovascular pharmacotherapy, 2019, 10-01, Volume: 5, Issue:4 Topics: Acute Coronary Syndrome; Anticoagulants; Aspirin; Atrial Fibrillation; Coronary Artery Disease; Factor Xa Inhibitors; Hemorrhage; Humans; Incidence; Percutaneous Coronary Intervention; Pyrazoles; Pyridones; Randomized Controlled Trials as Topic; Risk Assessment; Risk Factors; Treatment Outcome; Warfarin	2019
In AF with recent ACS or PCI, apixaban reduced bleeding vs VKAs; aspirin increased bleeding vs placebo. Annals of internal medicine, 2019, 07-16, Volume: 171, Issue:2 Topics: Acute Coronary Syndrome; Aspirin; Atrial Fibrillation; Fibrinolytic Agents; Humans; Percutaneous Coronary Intervention; Pyrazoles; Pyridones	2019
Effect of concomitant antiplatelet therapy in patients with nonvalvular atrial fibrillation initiating non-vitamin K antagonists. European journal of clinical investigation, 2019, Volume: 49, Issue:10 Topics: Aged; Aged, 80 and over; Antithrombins; Aspirin; Atrial Fibrillation; Dabigatran; Drug Therapy, Combination; Factor Xa Inhibitors; Female; Hemorrhage; Humans; Male; Mortality; Myocardial Infarction; Platelet Aggregation Inhibitors; Proportional Hazards Models; Purinergic P2Y Receptor Antagonists; Pyrazoles; Pyridines; Pyridones; Retrospective Studies; Rivaroxaban; Stroke; Thiazoles	2019
Apixaban enhances endogenous fibrinolysis in patients with atrial fibrillation. Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology, 2019, Sep-01, Volume: 21, Issue:9 Topics: Aged; Aged, 80 and over; Anticoagulants; Aspirin; Atrial Fibrillation; Blood Coagulation Tests; Cross-Sectional Studies; Factor Xa Inhibitors; Female; Fibrin Clot Lysis Time; Fibrinolysis; Humans; Ischemic Stroke; Longitudinal Studies; Male; Middle Aged; Platelet Aggregation Inhibitors; Prospective Studies; Pyrazoles; Pyridones; Thrombelastography; Warfarin	2019
Hospitalization Among Patients With Atrial Fibrillation and a Recent Acute Coronary Syndrome or Percutaneous Coronary Intervention Treated With Apixaban or Aspirin: Insights From the AUGUSTUS Trial. Circulation, 2019, 12-03, Volume: 140, Issue:23 Topics: Acute Coronary Syndrome; Aged; Anticoagulants; Aspirin; Atrial Fibrillation; Cardiovascular Agents; Combined Modality Therapy; Drug Therapy, Combination; Elective Surgical Procedures; Female; Fibrinolytic Agents; Hemorrhage; Hospitalization; Humans; Length of Stay; Male; Middle Aged; Multicenter Studies as Topic; Percutaneous Coronary Intervention; Platelet Aggregation Inhibitors; Proportional Hazards Models; Prospective Studies; Purinergic P2Y Receptor Antagonists; Pyrazoles; Pyridones; Randomized Controlled Trials as Topic; Survival Analysis; Treatment Outcome; Vitamin K	2019
Prevalence and Knowledge of Potential Interactions Between Over-the-Counter Products and Apixaban. Journal of the American Geriatrics Society, 2020, Volume: 68, Issue:1 Topics: Aged; Anti-Inflammatory Agents, Non-Steroidal; Anticoagulants; Aspirin; California; Cross-Sectional Studies; Dietary Supplements; Drug Interactions; Factor Xa Inhibitors; Female; Health Knowledge, Attitudes, Practice; Humans; Male; Nonprescription Drugs; Prevalence; Pyrazoles; Pyridones	2020
Bilateral paramedian pontine infarcts: a rare cause of bilateral horizontal gaze palsy. BMJ case reports, 2019, Oct-31, Volume: 12, Issue:10 Topics: Aged; Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Atrial Flutter; Brain; Cerebral Infarction; Diagnosis, Differential; Diplopia; Factor Xa Inhibitors; Headache; Humans; Magnetic Resonance Imaging; Male; Ophthalmoplegia; Pons; Pyrazoles; Pyridones; Stroke; Treatment Outcome	2019
Efficacy of Cangrelor as Bridging Therapy Post PCI. Cardiovascular & hematological disorders drug targets, 2020, Volume: 20, Issue:3 Topics: Adenosine Monophosphate; Aged; Aspirin; Colectomy; Colonic Neoplasms; Drug-Eluting Stents; Factor Xa Inhibitors; Humans; Male; Percutaneous Coronary Intervention; Platelet Aggregation Inhibitors; Purinergic P2Y Receptor Antagonists; Pyrazoles; Pyridones; Thrombosis; Ticagrelor	2020
Diffuse saphenous vein graft thrombosis: resolution after one month of apixaban and dual antiplatelet therapy. Coronary artery disease, 2020, Volume: 31, Issue:8 Topics: Aged; Aspirin; Clopidogrel; Coronary Angiography; Coronary Artery Bypass; Graft Occlusion, Vascular; Humans; Male; Non-ST Elevated Myocardial Infarction; Platelet Aggregation Inhibitors; Pyrazoles; Pyridones; Saphenous Vein; Thrombosis; Treatment Outcome	2020
Risk/Benefit Tradeoff of Antithrombotic Therapy in Patients With Atrial Fibrillation Early and Late After an Acute Coronary Syndrome or Percutaneous Coronary Intervention: Insights From AUGUSTUS. Circulation, 2020, 05-19, Volume: 141, Issue:20 Topics: Acute Coronary Syndrome; Aged; Anticoagulants; Aspirin; Atrial Fibrillation; Coronary Thrombosis; Factor Xa Inhibitors; Female; Fibrinolytic Agents; Hemorrhage; Humans; Ischemia; Male; Middle Aged; Percutaneous Coronary Intervention; Platelet Aggregation Inhibitors; Pyrazoles; Pyridones; Randomized Controlled Trials as Topic; Recurrence; Retrospective Studies; Risk Assessment; Risk Factors; Stroke; Time Factors; Treatment Outcome; Vitamin K	2020
Impact of Flow Dynamics on Device-Related Thrombosis After Left Atrial Appendage Occlusion. The Canadian journal of cardiology, 2020, Volume: 36, Issue:6 Topics: Aged; Antithrombins; Aspirin; Atrial Appendage; Atrial Fibrillation; Cardiac Catheterization; Computed Tomography Angiography; Echocardiography, Transesophageal; Equipment Failure Analysis; Female; Hemodynamics; Humans; Postoperative Complications; Pyrazoles; Pyridones; Recurrence; Septal Occluder Device; Thrombosis	2020
Anticoagulation and Antiplatelet Therapy in Atrial Fibrillation: A Teachable Moment. JAMA internal medicine, 2020, 09-01, Volume: 180, Issue:9 Topics: Accidental Falls; Aged, 80 and over; Anticoagulants; Aspirin; Atrial Fibrillation; Drug Therapy, Combination; Humans; Male; Platelet Aggregation Inhibitors; Pyrazoles; Pyridones; Stroke; Warfarin	2020
[Antithrombotic Therapy in Patients with Acute Coronary Syndrome and Atrial Fibrillation]. Deutsche medizinische Wochenschrift (1946), 2020, Volume: 145, Issue:14 Topics: Acute Coronary Syndrome; Acute Disease; Aspirin; Atrial Fibrillation; Clopidogrel; Combined Modality Therapy; Cyclophosphamide; Dabigatran; Drug Therapy, Combination; Fibrinolytic Agents; Hemorrhage; Humans; Percutaneous Coronary Intervention; Platelet Aggregation Inhibitors; Pyrazoles; Pyridones; Randomized Controlled Trials as Topic; Risk Factors; Rivaroxaban; Stents; Stroke; Vitamin K	2020
In AF with recent ACS or PCI, apixaban improved 30-day outcomes vs. VKAs; aspirin effects varied vs. placebo. Annals of internal medicine, 2020, 09-15, Volume: 173, Issue:6 Topics: Acute Coronary Syndrome; Aspirin; Atrial Fibrillation; Fibrinolytic Agents; Humans; Patients; Percutaneous Coronary Intervention; Platelet Aggregation Inhibitors; Pyrazoles; Pyridones	2020
Evaluation of the Age, Biomarkers, and Clinical History-Bleeding Risk Score in Patients With Atrial Fibrillation With Combined Aspirin and Anticoagulation Therapy Enrolled in the ARISTOTLE and RE-LY Trials. JAMA network open, 2020, 09-01, Volume: 3, Issue:9 Topics: Age Factors; Aged; Anticoagulants; Aspirin; Atrial Fibrillation; Biomarkers; Cohort Studies; Female; Humans; Male; Middle Aged; Platelet Aggregation Inhibitors; Pyrazoles; Pyridones; Risk Assessment; Warfarin	2020
Desmopressin with four-factor prothrombin complex concentrate for life-threatening bleeding: A case series. The American journal of emergency medicine, 2020, Volume: 38, Issue:12 Topics: Aged; Aged, 80 and over; Anticoagulants; Aspirin; Blood Coagulation Factors; Cerebral Hemorrhage, Traumatic; Cerebral Intraventricular Hemorrhage; Clopidogrel; Deamino Arginine Vasopressin; Female; Fractures, Bone; Hematoma; Hematoma, Subdural, Intracranial; Hemostatics; Humans; International Normalized Ratio; Intracranial Hemorrhage, Traumatic; Male; Middle Aged; Pelvic Bones; Platelet Aggregation Inhibitors; Pyrazoles; Pyridones; Retrospective Studies; Rivaroxaban; Subarachnoid Hemorrhage, Traumatic; Thrombosis; Warfarin	2020
Bilateral, vertical supranuclear gaze palsy following unilateral midbrain infarct. BMJ case reports, 2020, Nov-04, Volume: 13, Issue:11 Topics: Aspirin; Atrial Fibrillation; Betacoronavirus; Blindness; Brain Stem Infarctions; Coronavirus Infections; COVID-19; Diplopia; Endocarditis, Bacterial; Factor Xa Inhibitors; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Ophthalmoplegia; Pandemics; Platelet Aggregation Inhibitors; Pneumonia, Viral; Pyrazoles; Pyridones; Retinal Artery Occlusion; SARS-CoV-2; Tomography, Optical Coherence; Treatment Outcome	2020
Short-Term Cessation of Dabigatran Causes a Paradoxical Prothrombotic State. Annals of neurology, 2021, Volume: 89, Issue:3 Topics: Aged; Aged, 80 and over; Animals; Antithrombins; Arachidonic Acid; Aspirin; Carotid Artery Thrombosis; Cerebral Infarction; Chlorides; Computed Tomography Angiography; Dabigatran; Deprescriptions; Factor Xa Inhibitors; Female; Ferric Compounds; Humans; Ischemic Stroke; Magnetic Resonance Angiography; Male; Mean Platelet Volume; Mice; Noxae; Pilot Projects; Platelet Aggregation; Platelet Aggregation Inhibitors; Platelet Count; Pyrazoles; Pyridones; Rivaroxaban; Severity of Illness Index; Substance Withdrawal Syndrome; Thrombin; Thrombophilia; X-Ray Microtomography	2021
A trial of antithrombotic therapy in patients with refractory migraine and antiphospholipid antibodies: A retrospective study of 75 patients. Lupus, 2021, Volume: 30, Issue:4 Topics: Adolescent; Adult; Aged; Antibodies, Antiphospholipid; Antiphospholipid Syndrome; Aspirin; Child; Clopidogrel; Cyclooxygenase Inhibitors; Female; Fibrinolytic Agents; Hemorrhage; Humans; Male; Middle Aged; Migraine Disorders; Purinergic P2Y Receptor Antagonists; Pyrazoles; Pyridones; Retrospective Studies; Severity of Illness Index; Stroke; Treatment Outcome; Young Adult	2021
Apixaban or Vitamin K Antagonists and Aspirin or Placebo According to Kidney Function in Patients With Atrial Fibrillation After Acute Coronary Syndrome or Percutaneous Coronary Intervention: Insights From the AUGUSTUS Trial. Circulation, 2021, 03-23, Volume: 143, Issue:12 Topics: Acute Coronary Syndrome; Aged; Aged, 80 and over; Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Atrial Fibrillation; Factor Xa Inhibitors; Female; Humans; Kidney; Male; Middle Aged; Percutaneous Coronary Intervention; Pyrazoles; Pyridones; Vitamin K	2021
Early stent thrombosis confirmed in a cancer patient receiving regorafenib, despite triple antithrombotic therapy: a case report. BMC cardiovascular disorders, 2021, 01-30, Volume: 21, Issue:1 Topics: Aged; Angiogenesis Inhibitors; Aspirin; Colorectal Neoplasms; Coronary Artery Disease; Coronary Thrombosis; Dual Anti-Platelet Therapy; Factor Xa Inhibitors; Fatal Outcome; Fibrinolytic Agents; Humans; Male; Percutaneous Coronary Intervention; Phenylurea Compounds; Platelet Aggregation Inhibitors; Prasugrel Hydrochloride; Pyrazoles; Pyridines; Pyridones; Risk Factors; Stents; Treatment Outcome; Venous Thrombosis	2021
Adverse Events Associated With the Addition of Aspirin to Direct Oral Anticoagulant Therapy Without a Clear Indication. JAMA internal medicine, 2021, 06-01, Volume: 181, Issue:6 Topics: Anticoagulants; Aspirin; Atrial Fibrillation; Dabigatran; Drug Therapy, Combination; Female; Hemorrhage; Humans; Male; Pyrazoles; Pyridines; Pyridones; Registries; Rivaroxaban; Thiazoles; Venous Thromboembolism	2021
Cost-effectiveness analysis of apixaban versus vitamin K antagonists for antithrombotic therapy in patients with atrial fibrillation after acute coronary syndrome or percutaneous coronary intervention in Spain. PloS one, 2021, Volume: 16, Issue:11 Topics: Acute Coronary Syndrome; Aged; Aspirin; Atrial Fibrillation; Cost-Benefit Analysis; Female; Fibrinolytic Agents; Humans; Male; Markov Chains; Percutaneous Coronary Intervention; Pyrazoles; Pyridones; Quality-Adjusted Life Years; Spain	2021
Coexistence of SARS-CoV-2 and cerebrovascular diseases: does COVID-19 positivity trigger cerebrovascular pathologies? Journal of infection in developing countries, 2022, 06-30, Volume: 16, Issue:6 Topics: Aspirin; Brain Ischemia; Cerebrovascular Disorders; Clopidogrel; COVID-19; Enoxaparin; Humans; Mannitol; Nervous System Diseases; Piracetam; Pyrazoles; Pyridones; Retrospective Studies; SARS-CoV-2	2022
Apixaban Anticoagulation in Children and Young Adults Supported With the HeartMate 3 Ventricular Assist Device. ASAIO journal (American Society for Artificial Internal Organs : 1992), 2023, 06-01, Volume: 69, Issue:6 Topics: Adolescent; Anticoagulants; Aspirin; Child; Heart Failure; Heart-Assist Devices; Humans; Retrospective Studies; Treatment Outcome; Young Adult	2023
Over-the-Counter Product-Apixaban Interactions: Patient Perspectives on Information-Seeking. Annals of family medicine, 2023, 01-01, Issue:21 Suppl 1 Topics: Adult; Aspirin; Female; Humans; Information Seeking Behavior; Male; Nonprescription Drugs; Pyrazoles	2023